Mojisola Adeyeye
Mojisola Adeyeye is a renowned pharmacologist and the current Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC) in Nigeria. She is recognized for her significant contributions to the field of pharmacology and her efforts to ensure the safety and efficacy of drugs in Nigeria.
Early Life and Education[edit | edit source]
Mojisola Adeyeye was born in Nigeria. She completed her Bachelor's degree in Pharmaceutics from the University of Nigeria, Nsukka. She then pursued her Master's degree in Pharmaceutics from the University of Georgia, Athens, USA. She further obtained her Ph.D. in Pharmaceutics from the University of Nigeria, Nsukka.
Career[edit | edit source]
Adeyeye began her career as a pharmacist in Nigeria. She later moved to the United States, where she worked as a professor of Pharmaceutics, Manufacturing Science and Drug Product Evaluation at the College of Pharmacy, Roosevelt University in Schaumburg, Illinois.
In November 2017, she was appointed as the Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC) in Nigeria. In this role, she has been instrumental in implementing stringent measures to ensure the safety and efficacy of drugs in the country.
Contributions to Pharmacology[edit | edit source]
Adeyeye has made significant contributions to the field of pharmacology. She has conducted extensive research in the areas of drug delivery systems and nanotechnology. Her work has led to the development of innovative drug delivery systems, which have significantly improved the efficacy of drugs.
She has also been involved in the development of regulatory policies for drugs in Nigeria. Her efforts have led to the implementation of stringent measures to ensure the safety and efficacy of drugs in the country.
Awards and Recognition[edit | edit source]
Adeyeye has received numerous awards and recognition for her contributions to the field of pharmacology. She was awarded the International Pharmaceutical Federation (FIP) Fellowship in 2017 for her significant contributions to the field of pharmacy and pharmaceutical sciences.
See Also[edit | edit source]
- Pharmacology
- National Agency for Food and Drug Administration and Control
- Drug delivery system
- Nanotechnology
References[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD